Australia's most trusted
source of pharma news
Posted 5 June 2026 AM
Kisunla drug maker, Eli Lilly joined more than 550 leading clinicians and researchers this week at the Australian Dementia Research Forum (ADRF) in Sydney as a Dimond Sponsor, presenting evidence and real-world data that the company says should build confidence in earlier, more accurate diagnoses of Alzheimer’s disease.
The theme for ADRF 2026 was Towards Healthy Brains for All: Precision, Prevention and Participation, with sessions highlighting emerging innovations and advances across the field.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.